[Gene therapy and Alzheimer's disease]

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
• Pathological hallmarks include beta-amyloid plaques, tau tangles, neuronal loss, and cerebrovascular amyloidosis.
• Clinical symptoms encompass memory loss, cognitive decline, behavioral changes, and language deficits.

Purpose of the Study:

• To explore gene therapy as a novel treatment strategy for Alzheimer's disease.
• To investigate the potential of vector-mediated gene transfer for therapeutic protein expression or gene silencing in AD.

Main Methods:

• Gene therapy utilizing vector-mediated gene transfer.
• Delivery of DNA or RNA into target cells within the brain.

Main Results:

• Gene therapy aims to promote the expression of protective or therapeutic proteins.
• Gene therapy can potentially silence specific virulence genes implicated in AD pathogenesis.

Conclusions:

• Current Alzheimer's disease therapies offer only symptomatic relief.
• Gene therapy presents a promising approach for addressing the underlying mechanisms of Alzheimer's disease.